RAI1 and Smith-Magenis syndrome: Then we compared SMS patients harboring RAI1 mutations within the N-terminal half or at the C-terminal half and no significant differences in clinical presentation were found suggesting a common molecular mechanism for the SMS pathogenesis despite the functional domain of the protein that is affected.